Abstract
Interleukin-1β (IL-1β) activates inflammatory mediator cascades and has been implicated in the pathogenesis of several diseases. Single nucleotide polymorphisms (SNPs) of the IL1B promoter have been associated with various inflammatory diseases. We recently reported that IL1B gene transcription was influenced by four promoter SNPs, and that individual SNP function in vitro was governed by haplotype context. In the present study we tested the in vivo relevance of this observation by comparing IL1B promoter haplotype-pairs with IL-1β protein levels in 900 gingival tissue fluid samples. Three SNPs (−511, −1464, −3737) defined four IL1B promoter haplotypes that occurred in the study population and could be assigned unambiguously to each chromosome. The four haplotypes defined ten haplotype-pairs of which four pairs, representing 57% of the population, were associated with 28–52% higher IL-1β protein levels in vivo. Two of these pairs, characterized by homozygosity for the common allele at −3737, were also associated with raised serum levels of C-reactive protein (p = 0.02). We validated these findings in stimulated peripheral blood mononuclear cells (PBMCs) from a separate population (N = 70). PBMCs with IL1B haplotype-pairs associated with higher in vivo levels of IL-1β produced 86–287% more IL-1β in vitro than the reference group. We believe that this is the first demonstration of a relationship between in vivo levels of an inflammatory mediator and gene promoter haplotypes on both chromosomes. These findings may apply to other inducible genes and could provide a logical framework for exploring disease risk related to genetic variability in pathogenic mediators.
Similar content being viewed by others
References
Adjers K, Pessi T, Karjalainen J, Huhtala H, Hurme M (2004) Epistatic effect of IL1A and IL4RA genes on the risk of atopy. J Allergy Clin Immunol 113:445–447
Armitage GC (2004) Analysis of gingival crevice fluid and risk of progression of periodontitis. Periodontol 2000 34:109–119
Berger P, McConnell JP, Nunn M, Kornman KS, Sorrell J, Stephenson K, Duff GW (2002) C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 17:171–174
Bo S, Gambino R, Uberti B, Mangiameli MP, Colosso G, Repetti E, Gentile L, Cassader M, Pagano GF (2005) Does C-reactive protein identify a subclinical metabolic disease in healthy subjects? Eur J Clin Invest 35:265–270
Brett PM, Zygogianni P, Griffiths GS, Tomaz M, Parkar M, D’Aiuto F, Tonetti M (2005) Functional gene polymorphisms in aggressive and chronic periodontitis. J Dent Res 84:1149–1153
Camargo MC, Mera R, Correa P, Peek RM Jr., Fontham ET, Goodman KJ, Piazuelo MB, Sicinschi L, Zabaleta J, Schneider BG (2006) Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1674–1687
Capri M, Salvioli S, Sevini F, Valensin S, Celani L, Monti D, Pawelec G, De Benedictis G, Gonos ES, Franceschi C (2006) The genetics of human longevity. Ann N Y Acad Sci 1067:252–263
Champagne CM, Buchanan W, Reddy MS, Preisser JS, Beck JD, Offenbacher S (2003) Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontol 2000 31:167–180
Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, Rafie-Kolpin M, Hsieh CM, Kornman KS, Duff GW (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15:519–529
Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW (1998) An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 62:1180–1188
Curran JE, Jowett JB, Elliott KS, Gao Y, Gluschenko K, Wang J, Abel Azim DM, Cai G, Mahaney MC, Comuzzie AG, Dyer TD, Walder KR, Zimmet P, MacCluer JW, Collier GR, Kissebah AH, Blangero J (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37:1234–1241
di Giovine FS, Camp N, Cox A, Chaudhary A, Crane A, Duff G (2000) Detection and population analysis of IL-1 and TNF gene polymorphisms in Cytokine Molecular Biology. Oxford University Press, Oxford
Dinarello CA (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16:457–499
Ebersole JL, Singer RE, Steffensen B, Filloon T, Kornman KS (1993) Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis and periodontitis sites. J Periodontal Res 28:543–546
El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr., Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402
Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR (2007) Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res
Florez O, Zafra G, Morillo C, Martin J, Gonzalez CI (2006) Interleukin-1 gene cluster polymorphism in chagas disease in a Colombian case-control study. Hum Immunol 67:741–748
Graves DT, Cochran D (2003) The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74:391–401
Haggerty CL, Ferrell RE, Hubel CA, Markovic N, Harger G, Ness RB (2005) Association between allelic variants in cytokine genes and preeclampsia. Am J Obstet Gynecol 193:209–215
Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508–519
Hung YC, Hong MY, Huang GS (2006) Cholesterol loading augments oxidative stress in macrophages. FEBS Lett 580:849–861
Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D’Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25:222–227
Ioannidis JP, Kavvoura FK (2006) Concordance of functional in vitro data and epidemiological associations in complex disease genetics. Genet Med 8:583–593
Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C (2006) IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 19:50–56
Kardys I, Knetsch AM, Bleumink GS, Deckers JW, Hofman A, Stricker BH, Witteman JC (2006) C-reactive protein and risk of heart failure. The Rotterdam Study. Am Heart J 152:514–520
Karouzakis E, Neidhart M, Gay RE, Gay S (2006) Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 106:8–13
Kornman KS (2006) Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am J Clin Nutr 83:475S–483S
Kozlowski P, Miller DT, Zee RY, Danik JS, Chasman DI, Lazarus R, Cook NR, Ridker PM, Kwiatkowski DJ (2006) Lack of association between genetic variation in 9 innate immunity genes and baseline CRP levels. Ann Hum Genet 70:574–586
Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, Rhee JC, Song SY, Sohn TS (2004) Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol 39:429–433
Listman JA, Wara-Aswapati N, Race JE, Blystone LW, Walker-Kopp N, Yang Z, Auron PE (2005) Conserved ETS Domain Arginines Mediate DNA Binding, Nuclear Localization, and a Novel Mode of bZIP Interaction. J Biol Chem 280:41421–41428
McGeer PL, Rogers J, McGeer EG (2006) Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 9:271–276
Muraki Y, Tsutsumi A, Takahashi R, Suzuki E, Hayashi T, Chino Y, Goto D, Matsumoto I, Murata H, Noguchi E, Sumida T (2004) Polymorphisms of IL-1 beta gene in Japanese patients with Sjogren’s syndrome and systemic lupus erythematosus. J Rheumatol 31:720–725
Napoleone E, Di Santo A, Camera M, Tremoli E, Lorenzet R (2000) Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 86:139–143
Nicklin MJ, Barton JL, Nguyen M, FitzGerald MG, Duff GW, Kornman K (2002) A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79:718–725
Offenbacher S, Barros S, Champagne CM, Moss K, Welborn A, Levy RI, Lin D, Beck JD (2005) Diagnosis of periodontal disease at the periodontal tissue-biofilm interface: biological correlates. Oral Biosci Med 213:215–220
Offenbacher S, Barros SP, Singer RE, Moss K, Williams RC, Beck JD (2007) Periodontal disease at the biofilm-gingival interface. J Periodontol 78:1911–1925
Orozco A, Gemmell E, Bickel M, Seymour GJ (2006) Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 21:256–260
Papp AC, Hatzakis H, Bracey A, Wu KK (1989) ARIC hemostasis study—I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61:15–19
Rainero I, Bo M, Ferrero M, Valfre W, Vaula G, Pinessi L (2004) Association between the interleukin-1alpha gene and Alzheimer’s disease: a meta-analysis. Neurobiol Aging 25:1293–1298
Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363–369
Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1998a) Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425–428
Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E (1998b) Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98:839–844
Rosenwasser LJ (1998) Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol 102:344–350
Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425–434
Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 52:168–174
Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, Binetti G, Bonvicini C, Squitti R, Palermo MT, Davis DG, Antuono P, Wekstein DR, Dobrina A, Gennarelli M, Fazio VM (2005) Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 26:455–464
Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793–1801
Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y (2005) Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol 40:530–539
Wen AQ, Wang J, Feng K, Zhu PF, Wang ZG, Jiang JX (2006) Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock 26:25–30
Woloshin S, Schwartz LM (2005) Distribution of C-reactive protein values in the United States. N Engl J Med 352:1611–1613
Acknowledgments
The study was supported in part by Interleukin Genetics. The Atherosclerosis Risk in Communities (ARIC) Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022 and Grant. R01-DE11551 from the National Institute of Dental Research. The authors thank the staff and participants of the ARIC Study for their important contributions. MIUR (Ministero dell’Università e Ricerca, Italia) -Programma Triennale di Ricerca, grant D. 1588, supported the in vitro peripheral blood mononuclear cell work by Catholic University in Campobasso, Italy. Drs. Kornman, Rogus, and Huttner are employees of Interleukin Genetics. Dr. Duff is a scientific advisor to Interleukin Genetics, and Dr. Wang is a consulting statistician for Interleukin Genetics.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rogus, J., Beck, J.D., Offenbacher, S. et al. IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1β and C-reactive protein. Hum Genet 123, 387–398 (2008). https://doi.org/10.1007/s00439-008-0488-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-008-0488-6